BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Santacruz-sanmartín E, Hincapié-palacio D, Ospina MC, Perez-toro O, Bernal-restrepo LM, Buitrago-giraldo S, Lenis-ballesteros V, Díaz FJ. Seroprevalence of mumps in an epidemic period in Medellín, Colombia. Vaccine 2015;33:5606-12. [DOI: 10.1016/j.vaccine.2015.08.088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Hincapié D, Acevedo M, Hoyos MC, Ochoa J, González C, Pérez PA, Molina A, Restrepo BI, Arrubla M, Echeverri AP, Almanza RE, González LD, Santacruz-Sanmartín E, Orrego NE, Arango D, Gutiérrez AM, Londoño OL, Toro LM, Ríos M, Villada O, Mejía LA, Arenas PA, García D, Osorio E. Serosurveillance for vaccine-preventable diseases: A look inside the pertussis experience. Biomedica 2019;39:130-43. [PMID: 31529840 DOI: 10.7705/biomedica.v39i4.4181] [Reference Citation Analysis]
2 Zhou C, Song W, Yin Z, Li S, Gong X, Fang Q, Wang S. Assessing the Changes of Mumps Characteristics with Different Vaccination Strategies Using Surveillance Data: Importance to Introduce the 2-Dose Schedule in Quzhou of China. J Immunol Res 2020;2020:8130760. [PMID: 32300606 DOI: 10.1155/2020/8130760] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Méndez-Herrera A, Arias-Toledo E, Sánchez-Alemán M, Olamendi-Portugal ML, Ruiz-Gómez J, Díaz-Ortega JL. [[Antibody prevalence to mumps in children and adolescents at two years of the introduction of the MMR vaccine]]. Salud Publica Mex 2018;60:71-6. [PMID: 29689659 DOI: 10.21149/8138] [Reference Citation Analysis]